The Reserve Bank of India has refused to let Uday Kotak to dilute promoter shareholding in Kotak Mahindra Bank through the non-convertible perpetual non-cumulative preference share (PNCPS) route.

On Thursday, Indian markets will open after a day’s break on account of Independence Day holiday and there are chances we may see a weak opening on account of sell-off seen in the global markets. Even if we see a weak opening, the zone of 11,265-11,285 is likely to act as a strong support zone. Stocks in news: Reliance Industries, Monsanto India, Siyaram Silk, Shilpa Medicare, UPL, UCO Bank and Kotak Mahindra Bank.

Indian markets are expected to make a cautious start as cues from global peers are not encouraging. Going ahead, market participants will have their eyes glued on the movement of the rupee. The SGX Nifty suggests that Nifty could open lower by 22 points at 11,412.  

Nifty PSU Index turned positive on Tuesday giving up its losing streak after two consecutive days of fall. Index registered a marginal gain of 0.34 per cent. The fall could be either a pullback in the form of profit booking or a reversal on the downside.

The company’s standalone revenue for the quarter came in at Rs. 500.69 crore as against Rs. 350.71 crore in the corresponding quarter last year, registering 42.8 per cent yoy increase.

Recent market correction which has been an eye opener for the investors who were in the hallucination of bull run in the past couple of years and were expecting very high returns from the equity funds. In the recent past almost every category except IT has witnessed erosion in the returns.

The PAT for the quarter came in at Rs. 4.82 crore as against Rs. 5.96 crore in the corresponding quarter last year yoy decline of 19.1 per cent.

Balkrishna Industries, the auto tyres and rubber products maker, surged more than 8 per cent in Tuesday’s trade with the F&O segment grabbing the top most position in the gainers’ list. The rally was on the back of robust Q1FY19 earnings performance by the company.

The company informed the bourses that it has received approval from the Maharashtra Pollution Control Board to manufacture Sulphuric Acid and Derivatives at its plant in Tarapur, Maharashtra on Tuesday.

Through this acquisition, the company aims to expand its pharma manufacturing footprint, said the company's filing to the exchange. The cost of acquisition is Rs. 155.55 crore and the deal will be completed by the end of September 2018